You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 5, 8 MAR 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acupuncture for Reflex Sympathetic Dystrophy

V. Fialka, MD; K. L. Resch, MD; D. Ritter-Dietrich, MD; Y. Alacamlioglu, MD; O. Chen, MD; T. Leitha, MD; R. Kluger, MD; E. Ernst, MD, PhD
Vienna, Austria

Arch Intern Med. 1993;153(5):661-665.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Reflex sympathetic dystrophy (RSD) is a frequent condition, usually occurring after trauma of the extremities characterized by pain, swelling, and dystrophy. Its pathophysiology is poorly understood, and no universally accepted treatment exists.1 We have tried classical acupuncture in a randomized, placebocontrolled pilot project on 14 patients with recent (less than 4 months) onset. Diagnosis was made clinically and was confirmed by scintigraphy in all cases. Group A received classical acupuncture five times per week for 3 weeks by an experienced acupuncturist (O.C.). Group B received sham-acupuncture, which meant that needles were inserted outside acupuncture points by the same acupuncturist. As the clinical evaluators (V.F. and Y.A.) were also blinded, the trial adhered as closely as possible to a double-blind protocol.

Both groups demonstrated a reduction of pain, as measured by visual analog scale (0 through 100) during the 3 weeks' treatment. In group A, the average reduction was from . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.